This brand name is authorized in Japan
The drug MUCOSTA contains one active pharmaceutical ingredient (API):
|
1
Rebamipide
UNII LR583V32ZR - REBAMIPIDE
|
|
Rebamipide, a gastroprotective drug, is a compound selected from over 500 amino acid analogs of 2(1H)-quinolinone. Rebamipide stimulates prostaglandin generation in gastric mucosa and improves not only the speed but also the quality of ulcer healing. Rebamipide works by enhancing mucosal defense, scavenging free radicals and temporarily activating genes encoding cyclooxygenase-2. |
Below package inserts are available for further reading:
| Title | Information Source | Document Type | |
|---|---|---|---|
| MUCOSTA Tablet | Web Search | MPI, Generic |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| Country: JP | 医薬品医療機器総合機構 | Identifier(s): 1319760Q1029, 2329021D1020, 2329021F1102 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
